AMGN -Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Pat... http://finance.yahoo.com/news/bayer-onyx-report-phase-3-073000128.html?soc_src=mediacontentstory